Walleye Capital LLC Takes $919,000 Position in National Health Investors, Inc. $NHI

Key Points

• Walleye Capital LLC has acquired a new stake in National Health Investors, Inc. (NYSE:NHI), purchasing 12,441 shares valued at approximately $919,000.
• National Health Investors recently announced an increase in its quarterly dividend to $0.92, representing a 4.7% yield on an annualized basis.
• The stock's consensus rating is "Buy" with a target price of $84.20, highlighting positive sentiment among analysts.

Walleye Capital LLC bought a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 12,441 shares of the real estate investment trust's stock, valued at approximately $919,000.

A number of other institutional investors and hedge funds have also made changes to their positions in NHI. Smartleaf Asset Management LLC raised its holdings in shares of National Health Investors by 49.8% in the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock valued at $33,000 after buying an additional 147 shares during the last quarter. GF Fund Management CO. LTD. purchased a new stake in shares of National Health Investors in the fourth quarter valued at about $58,000. Farther Finance Advisors LLC raised its holdings in National Health Investors by 5,000.0% during the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock worth $68,000 after purchasing an additional 900 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in National Health Investors in the fourth quarter valued at about $83,000. Finally, Jupiter Asset Management Ltd. acquired a new stake in National Health Investors in the first quarter valued at about $206,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Up 0.9%

Shares of National Health Investors stock opened at $78.33 on Friday. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $86.13. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.72 billion, a PE ratio of 25.02, a price-to-earnings-growth ratio of 3.36 and a beta of 0.73. The company has a 50-day moving average of $72.74 and a two-hundred day moving average of $72.90.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same period last year, the company posted $1.18 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. On average, research analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.7%. This is a boost from National Health Investors's previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. National Health Investors's dividend payout ratio is 115.02%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective on the stock in a report on Thursday, July 10th. Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Wells Fargo & Company lifted their price objective on National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday. Finally, Truist Financial lifted their price objective on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a report on Friday, August 15th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $84.20.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.